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Background: Liver donor shortages stimulate the development of strategies that incorporate damaged organs into
the donor pool. Herein we present a simplified machine perfusion system without the need for oxygen carriers or
temperature control, which we validated in a model of orthotopic liver transplantation.
Methods: Rat livers were procured and subnormothermically perfused with supplemented Williams E medium for 3
hours, then transplanted into healthy recipients (Fresh-SNMP group). Outcome was compared with static cold
stored organs (UW-Control group). In addition, a rat liver model of donation after cardiac death was adapted using
a 60-minute warm ischemic period, after which the grafts were either transplanted directly (WI group) or
subnormothermically perfused and transplanted (WI-SNMP group).
Results: One-month survival was 100% in the Fresh-SNMP and UW-Control groups, 83.3% in the WI-SNMP group
and 0% in the WI group. Clinical parameters, postoperative blood work and histology did not differ significantly
between survivors.
Conclusion: This work demonstrates for the first time in an orthotopic transplantation model that ischemically
damaged livers can be regenerated effectively using practical subnormothermic machine perfusion without oxygen
carriers.
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The discrepancy between the amount of livers trans-
planted annually and patients on the waiting list has been
growing over the past decade. In 2009, the waiting list
mortality rate was 15% in the United States (approxi-
mately 1,500 patients), whereas the transplantation rate
was about 38% (5,000 transplantations) [1]. This shortage
has driven scientific efforts to increase organ availability
targeted at upgrading conventional storage methods
(static cold storage (SCS) in University of Wisconsin
(UW) solution) or employing graft optimization to allow
for extension of donor criteria. First reported in 1967 [2],* Correspondence: k.uygun@partners.org; ireis@sbi.org
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in any medium, provided the original work is prmachine perfusion is a modality whereby organs can be
assessed, preserved and treated. In 2009, the first clinical
trial with hypothermic machine perfusion (HMP) of
human livers was conducted [3]. Besides preserving
organs [4], HMP can regenerate ischemic damage and
shows potential for reclaiming livers derived from dona-
tion after cardiac death (DCD) [5,6]. Although an
environment of hypothermia facilitates preservation by
slowing cellular metabolism and thereby reducing the
need for nutrients and oxygen, the low temperature can
cause damage to the microvasculature. Intravital micros-
copy of hypothermically perfused rat livers has demon-
strated that temperature-dependent cellular deformation
of sinusoidal endothelial cells obstructs flow, which con-
gests the sinusoid and decreases parenchymal perfusion
[4,7]. In addition, the lower temperature decreases the
fluidity of the plasma membrane, which can lead to celltral Ltd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
operly cited.
Berendsen et al. Transplantation Research 2012, 0:6 Page 2 of 10
http://www.transplantationresearch.com/content/0/1/6lysis and increased enzyme leakage [8]. It follows that be-
cause HMP is superior to SCS at temperatures where
metabolism is slowed, a separate, perhaps mechanistic
phenomenon contributes to this advantage [9,10]. One
possibility is that during machine perfusion, harmful
waste products are flushed out of the organ and the con-
tinuous flow facilitates better availability of the beneficial
solution to the peripheral parenchyma of the organ. In
addition to HMP, researchers in many studies have
explored normothermic machine perfusion (NMP) [11-17].
Because higher temperature involves increased metab-
olism, it becomes more essential to promote oxygen de-
livery, cellular function and bile homeostasis while
restricting adverse processes such as nutrient depletion,
apoptosis and cellular swelling. Raising the temperature
extends both the potential for resuscitation and the risk
of organ damage [11,13,14]. Although few studies have
compared HMP with NMP in the same setting, NMP
has been successful in regenerating warm ischemic
grafts and preserving livers in rat and porcine models,
proving its superiority over SCS [17-24].
Studies of machine perfusion have led to the need for
additional research, but new trials have been slow to
emerge. A potential reason lies in the relative complexity
of machine perfusion, which also has hampered its pro-
gress when introduced in kidney transplantation [25,26].
A simplified machine perfusion protocol might expedite
its implementation, benefiting from the practicality of
cold storage while not relinquishing the advantages of
machine perfusion. In this context, subnormothermic
machine perfusion (SNMP) may offer multiple advan-
tages: no temperature control and a moderate rate of
metabolism in which beneficial processes still occur
while adverse cellular processes may be controlled.
Coupled with metabolism at the temperatures used in
SNMP and NMP is the need for aerobic respiration. Al-
though erythrocytes or artificial oxygen carriers added to
the perfusate are effective in delivering oxygen to the
liver [11,18,27,28], Vairetti et al. successfully used oxyge-
nated SNMP without an oxygen carrier to investigate
the temperature-dependence and functional integrity of
the graft postperfusion [29,30]. Recently, Gringeri et al.
applied SNMP without an oxygen carrier to liver grafts
for 120 minutes in a porcine model of autotransplant-
ation [31]. Moreover, Tolboom et al. calculated the oxy-
gen use of livers during machine perfusion at 20°C and
30°C with an oxygen carrier and concluded that though
livers consume more oxygen at 37°C, the addition of the
oxygen carrier was not required for adequate liver metab-
olism at room temperature [32]. Currently, no studies are
underway to investigate the validity of SNMP without an
oxygen carrier in a long-term transplantation survival
model. Moreover, it has not been shown whether, similarly
to HMP [3,8,33] and NMP [13,15,16], ischemicallydamaged organs can be reclaimed and successfully trans-
planted using this technique.
In this study, we used a SNMP protocol that did not in-
volve dialysis, oxygen carriers or donor pretreatments such
as anticoagulants or preconditioning, enabling high-fidelity
simulation of DCD. We report herein for the first time
that both fresh and warm ischemic livers can be success-
fully treated by using such a system and transplanted into
healthy recipients with good 30-day survival.
Methods
Laboratory animals
Male Lewis rats weighing 250 to 300 g (Charles River
Laboratories, Boston, MA, USA) were used for trans-
plantation. The animals were maintained in accordance
with National Research Council guidelines, and the ex-
perimental protocols were approved by the Subcommit-
tee on Research Animal Care, Committee on Research,
Massachusetts General Hospital (Boston, MA, USA).
The animals were divided into four groups: the UW-
Control group (n= 4, 3 hours at 4°C, SCS preservation
and subsequent transplantation), the WI group (n = 4,
60 minutes at 34°C, warm ischemia and transplant-
ation), the Fresh-SNMP group (n= 6, 3 hours of SNMP
and transplantation) and the WI-SNMP group (n = 6,
60 minutes at 34°C, warm ischemia followed by 3 hours
of SNMP and then transplantation).
Liver procurement (all groups)
All surgical procedures were performed under aseptic
conditions. Each animal was weighed and anesthetized
with isoflurane (Baxter, Deerfield, IL, USA). The right
phrenic vein was ligated, and the liver was freed of its
surrounding ligaments. The infrahepatic vena cava
(IHVC) was mobilized and elongated by ligation and dis-
section of the adrenal vein, lumbar plexus and right
renal vein. The bile duct was cannulated (SURFLO 28-
gauge polyethylene stent; Terumo Medical Corp,
Somerset, NJ, USA) and dissected. The portal vein (PV)
was mobilized, and its most proximal side vessels (gas-
troduodenal and splenic veins) were ligated and cut. The
hepatic artery was ligated and dissected. The PV and
IHVC were cross-clamped, marking the start of ischemic
time, and the liver was excised from its recess and
weighed. Cuffs fashioned from 16- and 14-gauge intra-
venous catheters (Becton Dickinson, Franklin Lakes, NJ,
USA) were applied to the PV and IHVC as described by
Delrivière et al. [34]. The suprahepatic vena cava
(SHVC) was tailored for a sutured anastomosis.
Static cold storage group
SCS was performed using UW solution (CoStorSol;
Preservation Solutions, Inc, Elkhorn, WI, USA). No
other preservatives, pharmaceuticals or anticoagulants
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pared for transplantation and cold-stored for 3 hours
(matching the established machine perfusion time), then
transplanted as described below.DCD model (WI group and WI-SNMP group)
After procurement, the liver was placed without flushing
into a chamber filled with saline and maintained at
34.0 ± 0.1°C for 60 minutes. Ex vivo warm ischemia has
the advantage of temperature control and has been shown
to be a relevant and severe model of warm ischemia [35].Subnormothermic machine perfusion (Fresh-SNMP group
and WI-SNMP group)
Machine perfusion took place in a circuit that consisted of
a perfusion chamber, a peristaltic pump, a membrane oxy-
genator and a bubble trap (Figure 1). The liver was per-
fused through an 18-gauge intravenous catheter (Becton
Dickinson) that was connected to the PV cuff. Further
details of the perfusion system and technique can be found
elsewhere [36]. Temperature within the system was un-
controlled and constantly measured at 21.0°C. The total
perfusate volume was 350 ml and consisted of Williams
Medium E (Sigma-Aldrich, St Louis, MO, USA) supple-
mented with insulin (2 U/L Humulin; Eli Lilly & Co,
Indianapolis, IN, USA), penicillin (40,000 U/L)/strepto-
mycin (40,000 μg/L) (Gibco/Invitrogen, Camarillo, CA,
USA), L-glutamine (0.292 g/L; Gibco/Invitrogen), hydro-
cortisone (10 mg/L SOLU-CORTEF; Pharmacia &
Upjohn/Pfizer, New York, NY, USA) and heparin (1,000
U/L APP pharmaceuticals, Schaumberg, IL, USA). The
oxygenator used a mixture of 95% O2 and 5% CO2, with






Figure 1 Schematic of the subnormothermic machine perfusion systefluctuation in the perfusate pH (data not shown). Flow rate
was started at 8.0 ml/minute and was adjusted according
to the portal resistance, which was kept constant between
50 and 100 mM H2O. The total perfusion time chosen
was 180 minutes, in concurrence with ATP content recov-
ery of the grafts as detailed below, and in an effort to
minimize the risk of graft contamination while providing
sufficient organ recovery for transplantation.Perfusate analysis
Perfusate samples collected every 5 minutes for the first
20 minutes and on the half hour thereafter were tested
for alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) using InfinityTM ALT(GPT) and AST
(GOT) liquid stable reagent kits (Cellomics/Thermo
Electron, Pittsburgh, PA, USA). Every 30 minutes PV in-
flow and inferior vena cava (IHVC) outflow were
sampled and analyzed using a Bayer Rapidlab 845 blood
gas analyzer (Siemens Medical Solutions, Malvern, PA,
USA) to record the partial pressure of oxygen (pO2).
Those values were used to calculate the oxygen uptake
rate (OUR) as detailed previously [18]. Bile was col-
lected, quantified and reentered into the system.Tissue ATP content
Livers (n=3 per time point) were flash-frozen in liquid ni-
trogen directly after procurement (Fresh-SNMP group),
after 60 minutes of warm ischemia (WI group/WI-SNMP
group) and after 1, 2 and 3 hours of SNMP (Fresh-SNMP
group/WI-SNMP group). Various sections (n=7±1) were
sampled per liver. Cellular ATP levels were measured
using the ApoSENSOR ATP Luminescence Assay Kit
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(Fisher Scientific, Pittsburgh, PA, USA).
Orthotopic liver transplantation
Surgery was performed by TB in all cases according to
the technique invented by Kamada [37] and described in
detail by Delrivière et al. [34]. During the final 20 min-
utes of perfusion, the recipient hepatectomy was carried
out up to the start of the anhepatic phase. At the end of
machine perfusion, the liver was weighed and flushed
with sterile PBS containing 10 U/ml heparin. The recipi-
ent hepatectomy was completed, and the donor graft
was transplanted, starting with the SHVC anastomosis
using a Prolene 7–0 polypropylene suture (Ethicon, Inc,
Somerville, NJ, USA). Portal reperfusion occurred 13 to
17 minutes after the start of anhepatic time and approxi-
mately 20 to 30 minutes after the end of machine perfu-
sion. Anastomoses of the IVC and bile duct were
completed, the animal was administered 1 to 2 ml of
sterile PBS intravenously and the abdomen was irrigated
with warm PBS and closed. The skin was closed, and the
animal was placed under a heat lamp to recover.
Posttransplantation analysis
Blood samples (about 80 μl) were taken from transplant-
ation recipients by way of tail-snip hourly after the pro-
cedure for 3 hours, then daily for 7 days after the
surgery and finally after 30 days. The blood samples
were analyzed using a Piccolo xpress blood chemistry
analyzer and a metabolic panel (Abaxis North America,
Union City, CA, USA). The animals were inspected
regularly for signs of jaundice or infection and were
killed 30 days posttransplantation. The liver was mobi-
lized, resected and prepared for histology.
Histology
Livers from each group were sacrificed for histological
analysis. Samples were incubated overnight in formalin
and embedded in paraffin, then processed and stained
with H & E and terminal deoxynucleotidyltransferase 2′-
deoxyuridine 5′-triphosphate nick-end labeling
(TUNEL). As a negative control for cellular damage,
stains derived from fresh liver tissue were used, in com-
parison to samples from the preserved, treated and
transplanted groups. As a positive control for apoptosis,
the TUNEL stains from the WI group were used because
it has been reported that tissue from warm ischemic
liver can exhibit extensive cellular degeneration and
apoptosis [16,38,39].
Statistical analysis
A paired Student’s t-test was applied to compare values
for each parameter independently. The results were
deemed statistically significant if time point comparisonshad a P-value <0.05. Statistical significance is indicated
in each figure where applicable.
Results
Survival
Survival data are shown in Figure 2A. All recipients
from the UW-Control and Fresh-SNMP groups survived
the 30-day observation period. In the WI-SNMP group,
one animal died after approximately 72 hours and the
remaining five animals survived the 30-day period. All
animals in the WI-only group died within 24 hours
after transplantation. Body weight trends are shown in
Figure 2B. After an initial drop postoperatively, weight
gain resumed 7 to 14 days after transplantation in all
survivors. Liver recipients in the WI-SNMP group show
a significantly delayed recovery in body weight.
Subnormothermic machine perfusion
Physiological flow rates in the PV were determined pre-
viously at 1.7 to 2.3 ml/minute/g liver [40]. In our sys-
tem, portal flow rates were based on data from previous
experiments [32,41] and ranged from 0.8 to 1.2 ml/mi-
nute/g liver. The flow rate was adjusted to the portal
pressure, with the objective of keeping the portal pres-
sure constant. The hepatic vascular resistance is
expressed as a function of the portal flow and pressure
in Figure 3. It did not differ significantly between any of
the livers, with the exception of one liver (WI-SNMP
group) that showed markedly increased vascular resist-
ance throughout perfusion (Figure 3). The recipient of
this particular liver died on the third day posttransplan-
tation, the only nonsurvivor in the WI-SNMP group.
ATP analysis was performed to assess energetic deple-
tion during WI and recovery during SNMP (Figure 4).
After 60 minutes of warm ischemia, the average ATP con-
tent diminished to about 6% of fresh levels. This level was
restored after approximately 2.5 hours of SNMP, with ATP
values eventually exceeding the fresh ATP level.
During SNMP, the perfusate was analyzed for hepato-
cyte damage indicators. Figures 5A and 5B show cumu-
lative levels of ALT and AST. The levels of ALT, but not
of AST, were consistently higher in the WI-SNMP
group. Because these data are cumulative, the horizontal
trend in the graph indicates stabilization of transaminase
output in the perfusate.
The pO2 in the perfusate was used to calculate the OUR
(Figure 5C). The OUR was stable during SNMP, without
differences between the groups. The pO2 in the outflow
remained above 200 mmHg, indicating that the pO2 in the
inflow perfusate was sufficient for hepatic oxygenation.
As a determinant of synthetic function, bile production
is a prerequisite for successful transplantation [42]. In vivo
bile flow ranges from 15 to 20 μl/g liver in healthy rats.
During SNMP, bile flow averaged about 10 μl/g liver. It
Figure 2 Follow-up of recipients posttransplantation. (A) Survival rates of subnormothermically perfused fresh and warm ischemic (WI) livers,
as well as the simple cold storage (SCS) control group and the nonperfused WI group. (B) Body weights are normalized to preoperative weights.
Error bars = SD. *P< 0.05 between WI-SNMP and UW-Control groups. **P< 0.05 between WI-SNMP and both the Fresh-SNMP and UW-Control
groups.
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temperature during SNMP. Bile production was not sig-
nificantly higher in the Fresh-SNMP group than in the
WI-SNMP group (Figure 5D).
Posttransplantation blood analysis
Blood work was performed hourly for the first 3 hours,
then daily for 7 days and finally 30 days after transplant-
ation. The most relevant parameters include serum
transaminases (ALT and AST), total bilirubin (TB) and
blood urea nitrogen (BUN) (Figure 6). In the 3 hours fol-
lowing reperfusion, transaminases spiked, most promin-
ently in the WI-SNMP group (Figures 6A and 6B). Over
the next 7 days, ALT levels were significantly higher in
the WI-SNMP group, whereas the ALT levels in the
Fresh-SNMP and UW-Control groups remained slightlyFigure 3 Hepatic resistance (portal pressure/flow rate) during subnor
ischemic groups. Each line indicates a separate SNMP experiment (n= 6 pelevated. Levels of AST were higher in both the WI-
SNMP and Fresh-SNMP groups compared to the UW-
Control group. In the WI group, the levels of ALT and
AST climbed until death within the first 24 hours after
surgery (Figures 6A and 6B). The nonsurviving animal
in the WI-SNMP group displayed rapidly increasing
levels of both AST and ALT, with readings at t= 72 hours
in excess of 1,000 U/L. Among the surviving animals in
all groups, the levels of AST and ALT were within nor-
mal range (<80 U/L) after the 30-day period.
TB increased mildly over the first 7 days, which was
more apparent in the Fresh-SNMP group (Figure 6C).
At the end of the 30-day period, TB was increased to ap-
proximately 2 mg/dl in all surviving animals. BUN levels
were stable during the postoperative phase and through-
out the 30-day period (Figure 6D).mothermic machine perfusion (SNMP) of fresh and warm
er group).
Figure 5 Parameters studied during subnormothermic machine perfu
perfusion of fresh and warm ischemic (WI) livers showing levels of alanine
(C) and bile production (D). The in situ bars represent 30 minutes of bile co
treatment). Error bars = SD. *P< 0.05 between fresh and WI groups.
Figure 4 ATP analysis of fresh, warm ischemic and
subnormothermically perfused livers. Error bars = 95% CI.
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livers pre- and posttransplantation is displayed in Figure 7.
Although a few apoptotic cells were seen in all of the sam-
ples, including fresh liver (Figure 7A), there were no signs
of necrosis or cellular swelling, with the exception of the
WI group (Figure 7B). Pyknotic cells were observed
throughout this sample, indicating cellular degeneration.
After 3 hours of SNMP (WI-SNMP group) (Figure 7C),
this finding disappeared, so that the tissue histomorpholo-
gically resembled fresh liver tissue. At 30 days posttrans-
plantation, all groups showed normal hepatocellular
architecture and microvasculature (Figures 7D to 7F).
Hyperplasia of biliary epithelium was observed in all
transplanted livers, inherent to this model, which uses a
stent for the bile duct anastomosis.Discussion
SCS is practical and cost-effective but does not allow the
resuscitation of damaged grafts, which is vital to the
extended incorporation of marginal organs [43]. In
addition, evaluation of organ quality during SCS is lim-
ited to subjective assessments. To combine the simpli-
city of SCS with the therapeutic impact of machine
perfusion, we established a practical SNMP system thatsion of fresh and warm ischemic livers. Subnormothermic machine
aminotransferase (A), aspartate aminotransferase (B), oxygen uptake
llection in situ (in the 1-hour WI group, this collection predates the WI
Figure 6 Blood results post-transplantation included alanine aminotransferase (A), aspartate aminotransferase (B), total bilirubin (C)
and blood urea nitrogen (D). Error bars = SEM. *P< 0.05 between the WI-SNMP group and both the Fresh-SNMP and UW-Control groups.
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cial oxygen carriers. In an analogous study by our group,
this system was used to optimize livers for hepatocyte
isolation (ML Izamis, personal communication). Herein
we have shown that fresh livers could be preserved for 3
hours and transplanted successfully, with survival rates
and secondary outcomes equivalent to conventional cold
storage parameters. Furthermore, we used this system to
treat livers with sustained warm ischemia, which were
then successfully transplanted.
In the animal from the WI-SNMP group that died
within 72 hours after transplantation, the highly elevated
levels of AST and ALT point to primary nonfunction.
During treatment, the portal pressure of this liver was
significantly increased, suggesting a correlation between
high vascular resistance and graft failure. Although this
is a singular finding in our study, the principle of vascu-
lar resistance as a predictor of graft viability has been
suggested elsewhere [44]. We conclude that high vascu-
lar resistance during machine perfusion could serve as a
warning sign indicative of a mechanical or physiological
problem. However, specific research into this phenomenon
should be continued on a broad scale.
Cumulative ALT levels during SNMP were highest in the
WI-SNMP group. After 1 hour of SNMP, these levels
reached a plateau, signifying that the hepatocyte damage
caused by the WI period had been contained. Warm ische-
mic and fresh livers consumed similar amounts of oxygen
during the SNMP period. We observed that oxygen con-
sumption rates were not affected by the organ’s condition.We can conclude that resuscitation of a warm ischemic
liver to a transplantable state does not require more oxygen
than the SNMP preservation of a fresh liver. In addition,
the high residual oxygen content in the outflow perfusate
indicates that none of the livers exhausted the supply of
oxygen. Moreover, the ATP recovery of warm ischemic
livers beyond fresh levels also points to adequate aerobic
respiration in the ischemic grafts. Thus we conclude that
our system did not require an oxygen carrier.
The WI-SNMP group showed higher levels of trans-
aminase leakage posttransplantation, indicating that al-
though the livers were reclaimed adequately for
recipient survival, there was still regenerative potential
that remained unfulfilled. These observations are con-
current with the body weight trends: animals in all
groups initially lost weight, but the UW-Control and
Fresh-SNMP groups regained that weight sooner than
the WI-SNMP group. Possibly, SNMP was responsible
for only part of the restoration process and the remain-
der was carried out at the expense of the recipient. An-
other explanation may be that certain specific effects of
warm ischemia were not mitigated by the SNMP and
could be only restored by the recipients themselves, which
in this case were young and healthy animals. As rats have
great regenerative capacity, this phenomenon may be of
greater consequence in a higher-order species. Although
patients with end-stage liver disease are often in a fragile
physical state, it has been shown that human livers from
patients with elevated transaminases [45] or sustained
warm ischemia [46] can be successfully transplanted.
Figure 7 Histological appearance of liver grafts pre- and posttransplantation (H & E staining and terminal deoxynucleotidyltransferase
2′-deoxyuridine 5′-triphosphate nick-end labeling (TUNEL) staining, respectively). Top: sections from fresh liver, University of Wisconsin
(UW) solution group and WI-SNMP groups. Bottom: 30 days posttransplantation autopsic resections from all survivors (UW-Control group, Fresh-
SNMP and WI-SNMP groups).
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period will be clarified by continued investigation.
Conclusion
In this study, we have established a protocol for SNMP,
without oxygen carriers and without temperature con-
trol, that uses oxygenated and supplemented cell culture
medium as perfusate. We applied this system to demon-
strate feasibility against the current gold standard for the
preservation of fresh organs, as well as the potential for
regeneration of DCD grafts.
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